Literature DB >> 2536837

Identification of the major capsid protein gene of human cytomegalovirus.

M Chee1, S A Rudolph, B Plachter, B Barrell, G Jahn.   

Abstract

The coding region for the major capsid protein (MCP) of human cytomegalovirus (HCMV) was identified by comparing the protein sequence with the respective sequences of herpes simplex virus (HSV), Epstein-Barr virus, and varicella-zoster virus. The predicted length of the HCMV MCP was 1,370 amino acids. Comparison of the MCP sequences of the different human herpesviruses showed a homology of 25% to the MCP of HSV type 1, a homology of 29% to the MCP of Epstein-Barr virus, and a homology of 23% to the MCP of varicella-zoster virus. A subfragment of the HSV type 1 KpnI i fragment encoding the MCP VP5 cross-hybridized with the HCMV HindIII U fragment containing part of the MCP gene. Northern (RNA) blot analyses with subclones out of the coding region for the HCMV MCP detected one large transcript of about 8 kilobases. A portion of the open reading frame was expressed in Escherichia coli plasmid pBD2 IC2OH as a beta-galactosidase fusion protein and was used to generate polyclonal antibodies in New Zealand White rabbits. The obtained antisera reacted in Western immunoblots with the MCP of purified HCMV virions. A monoclonal antibody against the human MCP and a monospecific rabbit antiserum against strain Colburn of simian cytomegalovirus detected the fusion protein as well as the MCP of purified virions in immunoblots.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2536837      PMCID: PMC247832     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Physical mapping of herpes simplex virus-induced polypeptides.

Authors:  H S Marsden; N D Stow; V G Preston; M C Timbury; N M Wilkie
Journal:  J Virol       Date:  1978-11       Impact factor: 5.103

2.  Anatomy of herpes simplex virus (HSV) DNA. X. Mapping of viral genes by analysis of polypeptides and functions specified by HSV-1 X HSV-2 recombinants.

Authors:  L S Morse; L Pereira; B Roizman; P A Schaffer
Journal:  J Virol       Date:  1978-05       Impact factor: 5.103

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Filamentous coliphage M13 as a cloning vehicle: insertion of a HindII fragment of the lac regulatory region in M13 replicative form in vitro.

Authors:  J Messing; B Gronenborn; B Müller-Hill; P Hans Hopschneider
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Ultrasensitive stain for proteins in polyacrylamide gels shows regional variation in cerebrospinal fluid proteins.

Authors:  C R Merril; D Goldman; S A Sedman; M H Ebert
Journal:  Science       Date:  1981-03-27       Impact factor: 47.728

7.  A new computer method for the storage and manipulation of DNA gel reading data.

Authors:  R Staden
Journal:  Nucleic Acids Res       Date:  1980-08-25       Impact factor: 16.971

8.  Human cytomegalovirus: purification of enveloped virions and dense bodies.

Authors:  P Talbot; J D Almeida
Journal:  J Gen Virol       Date:  1977-08       Impact factor: 3.891

9.  Analysis of structural polypeptides of purified human cytomegalovirus.

Authors:  K S Kim; V J Sapienza; R I Carp; H M Moon
Journal:  J Virol       Date:  1976-12       Impact factor: 5.103

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  40 in total

1.  Specialization for Cell-Free or Cell-to-Cell Spread of BAC-Cloned Human Cytomegalovirus Strains Is Determined by Factors beyond the UL128-131 and RL13 Loci.

Authors:  Eric P Schultz; Jean-Marc Lanchy; Le Zhang Day; Qin Yu; Christopher Peterson; Jessica Preece; Brent J Ryckman
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

2.  Lack of association of herpesviruses with brain tumors.

Authors:  S Poltermann; B Schlehofer; K Steindorf; P Schnitzler; K Geletneky; J R Schlehofer
Journal:  J Neurovirol       Date:  2006-04       Impact factor: 2.643

3.  Control of cytoplasmic maturation events by cytomegalovirus tegument protein pp150.

Authors:  Ritesh Tandon; Edward S Mocarski
Journal:  J Virol       Date:  2008-07-23       Impact factor: 5.103

4.  Cytomegalovirus UL91 is essential for transcription of viral true late (γ2) genes.

Authors:  Shinya Omoto; Edward S Mocarski
Journal:  J Virol       Date:  2013-05-29       Impact factor: 5.103

5.  Transcription of true late (γ2) cytomegalovirus genes requires UL92 function that is conserved among beta- and gammaherpesviruses.

Authors:  Shinya Omoto; Edward S Mocarski
Journal:  J Virol       Date:  2013-10-16       Impact factor: 5.103

6.  Cytomegalovirus pUL96 is critical for the stability of pp150-associated nucleocapsids.

Authors:  Ritesh Tandon; Edward S Mocarski
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

7.  Proteins associated with purified human cytomegalovirus particles.

Authors:  C J Baldick; T Shenk
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

8.  Cytomegalovirus "missing" capsid protein identified as heat-aggregable product of human cytomegalovirus UL46.

Authors:  W Gibson; M K Baxter; K S Clopper
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

9.  Spliced transcripts of human cytomegalovirus.

Authors:  W D Rawlinson; B G Barrell
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

10.  Inactivation of enveloped virus by laser-driven protein aggregation.

Authors:  Shaw-Wei D Tsen; Travis Chapa; Wandy Beatty; Kong-Thon Tsen; Dong Yu; Samuel Achilefu
Journal:  J Biomed Opt       Date:  2012-12       Impact factor: 3.170

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.